Gosselies, Belgium, 4 May 2018, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today provides a business update for the first quarter ended 31 March 2018. Thomas Lienard, Chief Executive Officer of Bone Therapeutics, commented: “During the first quarter, we […]